Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen Completed Phase 2 Trials for Meningococcal Infections / Meningococcal Meningitis / Meningitis Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02199691Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents